Medicare Enrolled
Dr. Henry Vanpala, M.D.
Gastroenterology · Raleigh, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vanpala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanpala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vanpala
Dr. Henry Vanpala is a gastroenterology specialist in Raleigh, NC, with 14 years of NPI registration. Based on federal Medicare data, Dr. Vanpala performed 340 Medicare services across 218 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanpala received a total of $39,832 from 92 pharmaceutical and/or device companies across 2106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanpala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ 340 Medicare services
$39,832 industry payments
Medicare Practice Summary
Medicare Utilization ↗340
Medicare services
Bottom 32% in NC for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
218
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $76 | $106 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
89 | $113 | $113 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$39,832
Total received (2018-2024)
Avg $5,690/year across 7 years
Top 8% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
2,106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$39,641 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$191 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,051
2023
$6,178
2022
$8,278
2021
$6,661
2020
$3,329
2019
$4,794
2018
$4,541
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$716
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$539
Amgen Inc.
$418
AstraZeneca Pharmaceuticals LP
$413
Novo Nordisk Inc
$386
Phathom Pharmaceuticals, Inc.
$338
Axsome Therapeutics, Inc.
$324
PFIZER INC.
$301
Otsuka America Pharmaceutical, Inc.
$285
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$207
IDORSIA PHARMACEUTICALS US INC
$204
Lilly USA, LLC
$177
Sonex Health, Inc.
$151
Lundbeck LLC
$148
Ardelyx, Inc.
$117
Corcept Therapeutics
$116
Janssen Pharmaceuticals, Inc
$105
AIMMUNE THERAPEUTICS, INC.
$101
Bayer Healthcare Pharmaceuticals Inc.
$97
Verity Pharmaceuticals Inc.
$92
IBSA Pharma Inc.
$90
Exact Sciences Corporation
$83
QOL Medical, LLC
$77
Takeda Pharmaceuticals U.S.A., Inc.
$76
Teva Pharmaceuticals USA, Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Paratek Pharmaceuticals, Inc.
$54
Tolmar, Inc.
$52
Esperion Therapeutics, Inc.
$52
Antares Pharma, Inc.
$50
Novartis Pharmaceuticals Corporation
$44
Regeneron Healthcare Solutions, Inc.
$24
Merck Sharp & Dohme LLC
$18
Astellas Pharma US Inc
$18
Currax Pharmaceuticals LLC
$17
Radius Health, Inc.
$15
Acella Pharmaceuticals, LLC
$13
Top 3 companies account for 27.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$6,709
Novo Nordisk Inc
$3,934
AbbVie Inc.
$2,461
AstraZeneca Pharmaceuticals LP
$2,144
Lilly USA, LLC
$1,751
ABBVIE INC.
$1,504
Allergan Inc.
$1,424
Amarin Pharma Inc.
$1,217
Supernus Pharmaceuticals, Inc.
$905
Otsuka America Pharmaceutical, Inc.
$805
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$715
Takeda Pharmaceuticals U.S.A., Inc.
$669
ITI, Inc.
$666
PFIZER INC.
$592
Boehringer Ingelheim Pharmaceuticals, Inc.
$589
Eisai Inc.
$582
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$539
AbbVie, Inc.
$537
Allergan, Inc.
$534
Janssen Pharmaceuticals, Inc
$517
Teva Pharmaceuticals USA, Inc.
$514
IDORSIA PHARMACEUTICALS US INC
$477
Axsome Therapeutics, Inc.
$451
Antares Pharma, Inc.
$445
IBSA Pharma Inc.
$427
Clarus Therapeutics Inc.
$416
Currax Pharmaceuticals LLC
$365
Corcept Therapeutics
$357
Lundbeck LLC
$352
Esperion Therapeutics, Inc.
$351
Phathom Pharmaceuticals, Inc.
$338
Nestle HealthCare Nutrition Inc.
$318
GlaxoSmithKline, LLC.
$296
Tolmar, Inc.
$284
Merck Sharp & Dohme Corporation
$269
TherapeuticsMD, Inc.
$264
Paratek Pharmaceuticals, Inc.
$245
Bayer Healthcare Pharmaceuticals Inc.
$202
JAZZ PHARMACEUTICALS INC.
$199
Biohaven Pharmaceutical Holding Company Ltd.
$198
SANOFI-AVENTIS U.S. LLC
$196
Regeneron Healthcare Solutions, Inc.
$195
Astellas Pharma US Inc
$194
Exact Sciences Corporation
$190
Abbott Laboratories
$177
Gilead Sciences, Inc.
$177
Synergy Pharmaceuticals Inc
$169
Sonex Health, Inc.
$168
IMPEL PHARMACEUTICALS INC.
$147
QOL Medical, LLC
$146
Sunovion Pharmaceuticals Inc.
$133
Merck Sharp & Dohme LLC
$129
Ardelyx, Inc.
$117
Phadia US Inc.
$115
AIMMUNE THERAPEUTICS, INC.
$101
Bayer HealthCare Pharmaceuticals Inc.
$101
ARBOR PHARMACEUTICALS, INC.
$99
Endo Pharmaceuticals Inc.
$98
Novartis Pharmaceuticals Corporation
$97
Shield Therapeutics Inc
$96
Biohaven Pharmaceuticals, Inc.
$95
Verity Pharmaceuticals Inc.
$92
NESTLE HEALTHCARE NUTRITION INC.
$92
Boston Scientific Corporation
$86
Medtronic, Inc.
$83
Avanir Pharmaceuticals, Inc.
$78
VIVUS, Inc.
$77
E.R. Squibb & Sons, L.L.C.
$75
Nabriva Therapeutics, plc
$64
Aytu BioScience, Inc
$60
Acerus Pharmaceuticals Corporation
$56
EISAI INC.
$47
Arbor Pharmaceuticals, Inc.
$47
VIVUS LLC
$47
IRONWOOD PHARMACEUTICALS, INC
$46
FIDIA PHARMA USA INC.
$41
Nalpropion Pharmaceuticals, Inc.
$36
Azurity Pharmaceuticals, Inc.
$31
Nalpropion Pharmaceuticals LLC
$29
Avion Pharmaceuticals
$28
Genentech USA, Inc.
$26
Acella Pharmaceuticals, LLC
$26
Xeris Pharmaceuticals, Inc.
$25
Astellas Pharma Global Development
$20
Orexigen Therapeutics, Inc.
$18
Horizon Therapeutics plc
$18
Duchesnay USA Incorporated
$17
AMAG Pharmaceuticals, Inc.
$15
Radius Health, Inc.
$15
Adlon Therapeutics L.P.
$13
Bausch Health US, LLC
$11
Sumitomo Pharma America, Inc.
$11
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ACCRUFER · ADHANSIA XR · AIRSUPRA · AJOVY · ANNOVERA · ANORO · ANORO ELLIPTA · APLENZIN · AUSTEDO · AVEED · Adthyza · Aimovig · Amitiza · Auvelity · BASAGLAR · BELSOMRA · BIJUVA · BREZTRI · BYDUREON · BYSTOLIC · Balcoltra · Belviq · CAPLYTA · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · Creon · Dayvigo · Descovy · Dexilant · Divigel · EDEX · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · Evekeo · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 3 · GARDASIL · GATTEX · GEMTESA · GLASSIA · GVOKE PFS · Horizant · Hymovis · IBSRELA · IMVEXXY · INTELLIS · INTELLIS ADAPTIVESTIM · INTRAROSA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Levemir · Linzess · MOUNJARO · MOVANTIK · NEXLETOL · NEXLIZET · NOCDURNA · NP Thyroid 60 · NURTEC ODT · NUZYRA · Natesto · Nuedexta · ONZETRA XSAIL · OTREXUP · OXTELLAR XR · Osphena · Otezla · Otovel · Otrexup · Ozempic · PAXLOVID · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · Proclaim IPG · Prolia · QELBREE · QSYMIA · QULIPTA · QUVIVIQ · Qsymia · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · SUCRAID · SUNOSI · SX-ONE MICROKNIFE · SYMBICORT · Saxenda · Sivextro · Sucraid · Sunosi · TESTOPEL · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · Tirosint · Tlando · Tresiba · Trintellix · Trudhesa · Trulance · Truvada · Tymlos · UBRELVY · UTIBRON NEOHALER · Uloric · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIAFLEX · XIFAXAN · XYOSTED · Xenleta · Xofluza · Xultophy 100/3.6 · ZAVZPRET · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for gastroenterology in NC.
Geographic Context
Gastroenterologists within 10 mi
109
Per 100K population
9.5
County median income
$101,763
Nearest hospital
REX HOSPITAL
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vanpala is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of NC peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vanpala experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vanpala performed 251 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vanpala receive payments from pharmaceutical companies?
Yes. Dr. Vanpala received a total of $39,832 from 92 companies across 2,106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanpala's costs compare to other gastroenterologists in Raleigh?
Dr. Vanpala's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanpala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Raleigh
Browse gastroenterologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NC
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NC
Which NC gastroenterologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology